查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1408008

醫療保健分銷 -市場佔有率分析、行業趨勢/統計、2024-2029 年成長預測

Healthcare Distribution - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計醫療保健分銷市場在預測期內的複合年成長率為 6.5%。

新冠肺炎 (COVID-19) 大流行已成為與以往不同的全球公共衛生緊急事件。它影響了幾乎所有行業，包括醫療保健分銷，主要是由於醫療保健供應鏈的中斷。然而，公司透過其策略合作夥伴和製造商供應商已採取各種行動來管理供應鏈中的這些中斷。例如，康德樂 (Cardinal Health) 2021 年 12 月的一份報告發現，該公司與製造商和供應商密切合作，以支持產品的健康供應。據同一消息人士透露，該公司還在物流中心實施了新的倉庫管理系統，以應對醫療保健供應鏈中的課題。因此，由於企業應對供應鏈課題的策略，最初遭受適度負面影響的市場預計將在未來幾年發展。

在慢性病經濟負擔沉重的情況下，分銷技術的進步、有利的研發投資環境以及隨後藥品上市的增加是醫療保健分銷市場的關鍵促進因素。例如，2022年，美國國家慢性病和數據研究所報告稱，近60%的美國成年人至少患有一種慢性病，大約40%的成年人患有多種慢性病（MCC）。糖尿病、癌症和心血管疾病等慢性病是美國發病的主要原因。因此，對這些疾病的正確管理和診斷需要有效的醫療保健配送服務所需的各種醫療保健產品。因此，慢性疾病患者數量的增加正在推動醫療保健分銷市場。

技術進步和市場參與企業的新分銷策略預計將推動醫療保健分銷市場的發展。例如，2022年5月，日本通運推出了針對製藥業的物流服務，可以處理需要超低溫（~20度C至-85度C）的產品。這為公司提供了一個能夠嚴格控制溫度的醫藥物流平台。因此，這些醫療物流新平台預計將在預測期內保持市場的顯著成長。

然而，與醫療保健分銷服務相關的高成本和投資預計將阻礙該市場的整體成長。

醫療保健分銷市場的趨勢

預計零售藥局在預測期內將大幅成長

零售藥局（通常稱為社區藥局）向公眾和醫生供應和銷售藥品和保健相關產品，以及其他產品，如洗護用品、化妝品、小型保健設備和動物用藥品。,出售。零售藥局預計將推動這個市場，因為它們處理大量處方箋。在已開發國家，由於醫療保健系統和計劃的改善，處方箋數量顯著增加。

此外，市場參與企業之間關於零售藥局保健產品分銷的新協議可能會推動市場成長。例如，2022 年 9 月，McKesson Corporation 延長了與 CVS Health 的合作夥伴關係，並簽訂了原則協議，將在 2027 年 6 月之前向零售店、其他藥房和配銷中心分銷藥品。同樣，2022 年 6 月，BD (Becton, Dickinson, and Company) 和 Frazier Healthcare Partners 簽署了 BD 收購 Parata Systems 的最終協議。 Parata Systems 是一家為醫院、零售藥房和其他醫療保健環境提供藥房自動化解決方案的創新提供者。因此，這些協議預計將有助於醫療保健產品的有效供應並促進市場成長。

此外，高血壓、糖尿病、心血管疾病和癌症等需要長期服藥的慢性疾病的盛行率不斷上升，也與處方箋的增加直接相關。這可能會在預測期內進一步推動零售藥品市場的成長。例如，DiabetesAtlas.org 2021 報告稱，預計 2021 年約有 5.366 億人患有糖尿病，到 2030 年這一數字將增加到 6.427 億。因此，糖尿病等慢性病的高盛行率增加了對可從零售藥局購買的各種藥物的需求，預計該領域在預測期內將成長。

醫療保健分銷市場-IMG1
醫療保健分銷市場-IMG2

預計北美在預測期內將佔據主要市場佔有率

由於製藥和生物製藥行業的快速擴張、對特種藥物和學名藥的需求不斷成長以及人工智慧和區塊鏈等尖端技術在醫療領域的大規模採用等因素，北美有望佔據重要的市場佔有率。醫療保健領域，預計將佔據。

人工智慧技術的使用促進了全球分銷實踐。例如，SAGE 在 2021 年 9 月發表的一篇論文總結稱，透過使用人工智慧技術，企業可以為客戶提供摘要的出貨資訊。如果追蹤技術失敗，（人工智慧）人工智慧系統可以追蹤交付延遲，使企業能夠輕鬆估計向客戶交付的時間。這些人工智慧產品交付的更新可能會改善分銷服務並促進市場成長。

此外，該地區的大量處方箋增加了對各種醫療保健產品和分銷服務的需求。例如，根據 AssureCare LLC 2022 年 11 月發布的報告，2021 年美國處方箋量約為 64.7 億張，處於較高水平，預計未來幾年將進一步增加。此外，新的區域分銷協議可能會增加服務並提振市場。例如，2023 年3 月，Endonovo Therapeutics, Inc. 被佛羅裡達州西棕櫚灘的Academy Medical 選擇，以確保退伍軍人健康管理局(VHA) 和國防部(DoD) 合約的可用性。Inc.簽訂了一項服務-殘疾退伍軍人擁有的小型企業 (SDVOSB) 政府經銷商協議銷售 Sofpulse 醫療保健設備。因此，增加處方箋和新的醫療保健產品分銷合約可能會增加對醫療保健分銷服務的需求，並在預測期內促進市場成長。

醫療保健流通產業概述

醫療保健分銷市場本質上是分散的，既有在全球營運的公司，也有在區域營運的公司。競爭形勢包括 McKesson Corporation、Cardinal Health、Morris and Dickson Company、Smith Drug Company、Owens and Minor Inc.、Patterson Companies、PHOENIX Group、Owens、Medline Industries 等知名公司，市場佔有率包括對持有的幾家國際和本地公司的分析。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 慢性病發生率高，經濟負擔大
    • 分銷技術進步
    • 有利的研發投資情勢和相關藥物上市的增加
  • 市場抑制因素
    • 醫療保健分配高成本
  • 波特五力分析
    • 供應商的議價能力
    • 買家/消費者的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔（市場規模-美元）

  • 依產品類型
    • 藥品分銷服務
      • 成藥
      • 學名藥
      • 品牌藥品
    • 生物藥品分銷服務
      • 重組蛋白
      • 單株抗體
      • 疫苗
    • 醫療器材配送服務
  • 依最終用戶
    • 零售藥房
    • 醫院藥房
    • 其他最終用戶
  • 依地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 歐洲其他地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東/非洲
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭形勢

  • 公司簡介
    • McKesson Corporation
    • Cardinal Health
    • Morris and Dickson Company
    • Smith Drug Company
    • Owens and Minor Inc
    • Patterson Companies
    • PHOENIX Group
    • Shanghai Pharmaceutical Group
    • Medline Industries
    • CuraScript SD
    • Mutual Drug

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 91561
Healthcare Distribution - Market - IMG1

The healthcare distribution market is expected to register a CAGR of 6.5 % over the forecast period.

The COVID-19 pandemic was an incomparable global public health emergency. It impacted almost every industry sector, including healthcare distribution, mainly due to disruptions to the healthcare supply chain. However, the companies took various actions to manage these disruptions in the supply chain through their strategic partners and manufacturer suppliers. For instance, as per the report published by Cardinal Health in December 2021, the company worked closely with its manufacturer suppliers to help ensure a healthy supply of products. In addition, as per the same source, the company installed a new warehouse management system in many distribution centers to manage the challenges in the healthcare supply chain. As a result, the market originally had a modest negative impact but is anticipated to develop due to corporate strategies for addressing supply chain difficulties over the coming years.

With the large economic burden of chronic diseases, technological advancement in distribution, favorable R&D investment scenario, and subsequent increase in drug launches are the main driving factors of the healthcare distribution market. For instance, in 2022, the National Institution of Chronic Disease and Data reported that nearly 60% of American adults suffer from at least one chronic disease, and about 40% of adults include multiple chronic conditions (MCC). Chronic conditions like diabetes, cancer, and cardiovascular disease are the leading causes of morbidity in the United States. Hence, proper management and diagnosis of these diseases are needed with various healthcare products necessary for effective healthcare distribution services. Thus, increasing cases of chronic disease are driving the healthcare distribution market.

Technological advancements and new distribution strategies of market players are expected to boost the healthcare distribution market. For instance, in May 2022, Nippon Express Co., Ltd. launched a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry. With this, the company provided a pharmaceutical distribution platform with strict temperatures. Hence, these new platforms in healthcare distribution are expected to hold significant growth in the market over the forecast period.

However, the high cost and investment associated with healthcare distribution services are expected to hamper the overall growth of this market.

Healthcare Distribution Market Trends

Retail Pharmacy is Expected to Witness a Significant Growth Over the Forecast Period

Retail pharmacies (often known as community pharmacies) supply and sell medicine and medical-related products to the general public and medical practitioners, as well as other goods such as toiletries, cosmetics, small medical devices, and veterinary products. The retail pharmacy deals with many prescriptions and is thus expected to drive this market. In developed countries, the high availability of healthcare schemes and programs led to a significant increase in the number of prescriptions.

Furthermore, the new agreements among the market players for distributing healthcare products in retail pharmacies likely propel the market to grow. For instance, in September 2022, McKesson Corporation signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to retail and other pharmacies and distribution centers through June 2027. Similarly, in June 2022, BD (Becton, Dickinson, and Company) and Frazier Healthcare Partners entered a definitive agreement for BD to acquire Parata Systems. It is an innovative provider of pharmacy automation solutions for hospitals, retail pharmacies, and other healthcare settings. Thus, these agreements help supply healthcare products efficiently, which is expected to boost market growth.

Moreover, the growing incidence of chronic diseases like hypertension, diabetes, cardiovascular diseases, and cancer, which require prolonged medication, is directly related to increased prescriptions. It can further drive the growth of the retail pharmacy market during the forecast period. For instance, DiabetesAtlas.org 2021 reported that about 536.6 million people were estimated to suffer from diabetes in 2021, and this number will increase to 642.7 million by 2030. Thus, the high prevalence rate of chronic diseases like diabetes increases the need for various pharmaceuticals that can be procured from retail pharmacies and is expected to grow in the segment over the forecast period.

Healthcare Distribution - Market - IMG2

North America is Expected to hold Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant market share owing to factors such as the rapid expansion of the pharmaceutical and biopharmaceutical industry, rising demand for specialty drugs and generics, and large-scale adoption of advanced technologies such as Artificial Intelligence and blockchain in the healthcare sector.

The use of artificial intelligence technology boosted distribution practices globally. For instance, the article published by the journal SAGE in September 2021 summarizes that by using Artificial intelligence technology, businesses can offer shipment updates to customers. When tracking technology fails, an (Artificial Intelligence) AI system can track the delay in the delivery so companies can easily estimate delivery time to their customers. These updates on product delivery through AI increase the distribution services and likely boost the market to growth.

Furthermore, the significant number of prescriptions in the region increases the demand for various healthcare products and distribution services. For instance, as per the report published by AssureCare LLC in November 2022, in the United States, around 6.47 billion prescriptions were dispensed in 2021, which is high and is expected to increase more over the coming years. In addition, the new regional distribution agreements increase the services and likely boost the market. For instance, in March 2023, Endonovo Therapeutics, Inc. signed a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement (Agreement or Contract) with Academy Medical, Inc. of West Palm Beach, FL, to distribute SofPulse medical devices to ensure its availability to the Veterans Health Administration (VHA) and Department of Defense (DoD) contracts. Thus, increasing prescriptions and new agreements to distribute healthcare products will likely raise the demand for healthcare distribution services and boost the market growth over the forecast period.

Healthcare Distribution Industry Overview

The healthcare distribution market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known as McKesson Corporation, Cardinal Health, Morris and Dickson Company, Smith Drug Company, Owens and Minor Inc., Patterson Companies, PHOENIX Group, Owens, Medline Industries, and other Companies.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence and Large Economic Burden of Chronic Diseases
    • 4.2.2 Technological Advancement in Distribution
    • 4.2.3 Favorable R&D Investment Scenario, and Subsequent Increase in Drug Launches
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Healthcare Distribution
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Pharmaceutical Product Distribution Services
      • 5.1.1.1 Over The Counter Drugs
      • 5.1.1.2 Generic Drugs
      • 5.1.1.3 Branded Drugs
    • 5.1.2 Biopharmaceutical Product Distribution Service
      • 5.1.2.1 Recombinant Proteins
      • 5.1.2.2 Monoclonal Antibodies
      • 5.1.2.3 Vaccines
    • 5.1.3 Medical Devices Distribution Services
  • 5.2 By End-User
    • 5.2.1 Retail Pharmacies
    • 5.2.2 Hospital Pharmacies
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 McKesson Corporation
    • 6.1.2 Cardinal Health
    • 6.1.3 Morris and Dickson Company
    • 6.1.4 Smith Drug Company
    • 6.1.5 Owens and Minor Inc
    • 6.1.6 Patterson Companies
    • 6.1.7 PHOENIX Group
    • 6.1.8 Shanghai Pharmaceutical Group
    • 6.1.9 Medline Industries
    • 6.1.10 CuraScript SD
    • 6.1.11 Mutual Drug

7 MARKET OPPORTUNITIES AND FUTURE TRENDS